in Newswire Published on February 23, 2022

Class Action Alleges E25Bio Mislabeled Now-Recalled COVID-19 Tests

Urena v. E25Bio Inc.

Filed: February 18, 2022 § 1:22-cv-01379

A class action has been filed against E25Bio, Inc. in the wake of a recall of the company’s “highly inaccurate” COVID-19 direct antigen rapid tests.


E25Bio Inc.


New York

Case Spotlight

Hair Relaxer Lawsuits Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on February 23, 2022 — 4:39 PM

Corrado Rizzi

Corrado Rizzi is the Senior Managing Editor of

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.